Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Royalty Pharma PLC $RPRX Holdings Lifted by CM Management LLC
CM Management LLC grew its position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 50.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 75,000 shares of the…
PFA Pension Forsikringsaktieselskab Acquires New Holdings in Royalty Pharma PLC $RPRX
PFA Pension Forsikringsaktieselskab purchased a new position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund…
Hussman Strategic Advisors Inc. Buys New Stake in Royalty Pharma PLC $RPRX
Hussman Strategic Advisors Inc. acquired a new position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the fourth quarter, according to the company in its most recent filing with the SEC. The fund acquired 63,000 shares of the…
India needs a future-ready workforce to sustain its global leadership in pharmaceuticals: experts
Experts at a webinar underscored the need for India to strengthen its innovation ecosystem, streamline regulatory frameworks, and build a future-ready workforce to sustain its global leadership in pharmaceuticals. The webinar, “Pharma 2030:…
Is Doximity, Inc. (DOCS) A Good Stock To Buy Now?
Is DOCS a good stock to buy? We came across a bullish thesis on Doximity, Inc. on The Cash Flow Compounder's Substack. In this article, we will summarize the bulls' thesis on DOCS. Doximity, Inc.'s share was trading at $24.15 as of April 21st.
Drug Trafficker Dola's Chemist Links Under Investigation
Investigators are uncovering the network of Mohammad Salim Dola, an international drug trafficker, focusing on his connections with chemists and pharma dealers who allegedly facilitated his illicit operations. Mohammad Salim Dola, an alleged…
Bharat Future City set for fast-track growth ahead of Telangana Formation Day on June 2
Chief Minister A. Revanth Reddy is expected to launch a series of major government and private sector projects in the ambitious Bharat Future City region later this month, signalling the beginning of fast-track development in the proposed…
Is Precigen, Inc. (PGEN) A Good Stock To Buy Now?
Is PGEN a good stock to buy? We came across a bullish thesis on Precigen, Inc. on Valueinvestorsclub.com by coalone. In this article, we will summarize the bulls' thesis on PGEN. Precigen, Inc.'s share was trading at $4.0200 as of April 28. PGEN's…
Tour of Turkey: Sebastian Berwick seals overall title as Tom Crabbe triples up with uphill sprint on final stage
Sebastian Berwick (Caja Rural) was crowned the winner of the 2026 Tour of Turkey on Sunday, as Tom Crabbe (Flanders-Baloise) made it a hattrick of stage wins with victory on the final day. The finale to the eight-stage race once again saw wet…
Costly remedy
The landmark $11.75 billion buyout of US-based Organon by Sun Pharma impacts investors, policymakers and consumers. At the outset, there is a looming context that cannot be overlooked. The Trump administration, after having concluded its Section…
Global week ahead: Is 'Sell in May' just a myth?
May trading gets underway following a record-breaking April for certain stock markets. Deutsche Bank looks to bust the myth of the 'sell in May' adage. Earnings season in Europe and Asia is still in full swing. Global central banks sound the alarm…
NCB probes Dola's links with chemists, his Turkiye citizenship plans
Investigators probing the network of M ohammad Salim Dola, the alleged international drug trafficker brought back from Turkiye recently, have found his links with certain chemists and pharma dealers who were “aiding” the illicit…
Growth Stocks To Follow Now - May 3rd
Prologis Q1 2026: Data Centers Steal the Show Prologis, Teledyne Technologies, Ascendis Pharma A/S, Hamilton Lane, and Acadia Realty Trust are the five Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are…
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Receives Average Rating of 'Moderate Buy' from Brokerages
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Get Free Report) has been assigned an average rating of 'Moderate Buy' from the ten research firms that are currently covering the company, Marketbeat reports. One equities research analyst has rated…
Top news of the day | May 3, 2026
Kerala's voter turnout in the April 9 Assembly elections has tentatively risen to 79.7% after the inclusion of service voters' postal ballots, CEO Rathan U. Kelkar said. Addressing a press conference here, Mr. Kelkar also outlined elaborate…
Receive a Daily briefing on Pharma Industry News
Get Started